Multidimensional health status of HIV-infected outpatients at a tertiary care center in north India

Indian Journal of Medical Sciences

Volumn 62, Issue 3, 2008, Pages 87-97

  Wig, Naveet ^a   Sakhuja, Ankit ^a   Agarwal, Sunil ^a   Khakha, Deepika ^a   Mehta, Saurabh ^a   Vajpayee, Madhu ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

HIV; India; Multidimensional health status; Quality of life

Indexed keywords

ADULT; ARTICLE; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EMOTIONAL DISORDER; FEMALE; HEALTH STATUS; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; OUTPATIENT DEPARTMENT; PAIN; PATIENT INFORMATION; RATING SCALE; SAMPLING; SOCIAL BEHAVIOR; STRUCTURED QUESTIONNAIRE; TERTIARY HEALTH CARE; TUBERCULOSIS; WEIGHT REDUCTION; WORK CAPACITY;

EID: 41849128820     PISSN: 00195359     EISSN: 19983654     Source Type: Journal    
DOI: 10.4103/0019-5359.39611     Document Type: Article

References (55)

1. National AIDS Control Organisation (NACO). Facts and Figures. An Overview of the Spread and Prevalence of HIV/AIDS in India. Available from: http://nacoonline.org/facts_overview.htm. 2006.
2. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60.
3. AB Measuring disease. A review of quality of life measurement scales. Milton Keynes: Open University; 1995.
4. Wu AW, Rubin HR, Mathews WC, Ware JE Jr, Brysk LT, Hardy WD, et al. A health status questionnaire using 30 items from the Medical Outcomes Study: Preliminary validation in persons with early HIV infection. Med Care 1991;29:786-98.
5. Scott-Lennox JA, Mills RJ, Burt MS. Impact of zidovudine plus lamivudine or zalcitabine on health-related quality of life. Ann Pharmacother 1998;32:525-30.
6. Weinfurt KP, Willke RJ, Glick HA, Freimuth WW, Schulman KA. Relationship between CD4 count, viral burden and quality of life over time in HIV-1-infected patients. Med Care 2000;38:404-10.
7. Anderson JP, Kaplan RM, Coons SJ, Schneiderman LJ. Comparison of the quality of well-being scale and the SF-36 results among two samples of ill adults: AIDS and other illnesses. J Clin Epidemiol 1998;51:755-62.
8. Smith MY, Rapkin BD. Social support and barriers to family involvement in caregiving for persons with AIDS: Implications for patient education. Patient Educ Couns 1996;27:85-94.
9. Kaplan RM, Anderson JP, Patterson TL, McCutchan JA, Weinrich JD, Heaton RK, et al. Validity of the quality of well-being scale for persons with human immunodeficiency virus infection. Psychosom Med 1995;57:138-47.
10. Leplege A, Rude N, Ecosse E, Ceinos R, Dohin E, Pouchot J. Measuring quality of life from the point of view of HIV-positive subjects: The HIV-QL31. Qual Life Res 1997;6:585-94.
11. Holmes WC, Bix B, Meritz M, Turner J, Hutelmyer C. Human immunodeficiency virus (HIV) infection and quality of life: The potential impact of Axis I psychiatric disorders in a sample of 95 HIV seropositive men. Psychosom Med 1997;59:187-92.
12. Lubeck DP, Fries JF. Assessment of quality of life in early stage HIV-infected persons: Data from the AIDS Time-oriented Health Outcome Study (ATHOS). Qual Life Res 1997;6:494-506.
13. De Boer JB, Sprangers MA, Aaronson NK, Lange JM, van Dam FS. A study of the reliability, validity and responsiveness of the HIV overview of problems evaluation system (HOPES) in assessing the quality of life of patients with AIDS and symptomatic HIV infection. Qual Life Res 1996;5:339-47.
14. Smith KW, Avis NE, Mayer KH, Swislow L. Use of the MQoL-HIV with asymptomatic HIV-positive patients. Qual Life Res 1997;6:555-60.
15. Peterman AH, Cella D, Mo F, McCain N. Psychometric validation of the revised Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument. Qual Life Res 1997;6:572-84.
16. World Health Organization (WHO). The World Health Organization Quality of Life (WHOQOL)-BREF. Available from: http://www.who.int/substance_abuse/ research_tools/en/english_whoQoL.pdf.
17. Skevington SM, Lotfy M, O'Connell KA. The World Health Organization's WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial: A report from the WHOQOL group. Qual Life Res 2004;13:299-310.
18. Wig N, Lekshmi R, Pal H, Ahuja V, Mittal CM, Agarwal SK. The impact of HIV/AIDS on the quality of life: A cross sectional study in north India. Indian J Med Sci 2006;60:3-12.
19. Webb A, Norton M. Clinical assessment of symptom-focused health-related quality of life in HIV/AIDS. J Assoc Nurses AIDS Care 2004;15:67-78.
20. National AIDS Control Organisation (NACO). Facts and Figures. Monthly updates on AIDS. [Last updated on 2006 Aug 31]. Available from: http://nacoonline.org/facts_reportaug.htm.
21. Davis S. Clinical sequelae affecting quality of life in the HIV-infected patient. J Assoc Nurses AIDS Care 2004;15:28S-33S.
22. Trepanier LL, Rourke SB, Bayoumi AM, Halman MH, Krzyzanowski S, Power C. The impact of neuropsychological impairment and depression on health-related quality of life in HIV-infection. J Clin Exp Neuropsychol 2005;27:1-15.
23. Chandra PS, Ravi V, Desai A, Subbakrishna DK. Anxiety and depression among HIV-infected heterosexuals: A report from India. J Psychosom Res 1998;45:401-9.
24. Linsk NL, Mason S. Stresses on grandparents and other relatives caring for children affected by HIV/AIDS. Health Soc Work 2004;29:127-36.
25. Barfod TS, Gerstoft J, Rodkjaer L, Pedersen C, Nielsen H, Moller A, et al. Patients' answers to simple questions about treatment satisfaction and adherence and depression are associated with failure of HAART: A cross-sectional survey. AIDS Patient Care STDS 2005;19:317-25.
26. Cheer SM, Goa KL. Fluoxetine: A review of its therapeutic potential in the treatment of depression associated with physical illness. Drugs 2001;61:81-110.
27. Phillips KD, Sowell RL, Rojas M, Tavakoli A, Fulk LJ, Hand GA. Physiological and psychological correlates of fatigue in HIV disease. Biol Res Nurs 2004;6:59-74.
28. Millikin CP, Rourke SB, Halman MH, Power C. Fatigue in HIV/AIDS is associated with depression and subjective neurocognitive complaints but not neuropsychological functioning. J Clin Exp Neuropsychol 2003;25:201-15.
29. Breitbart W, McDonald MV, Rosenfeld B, Monkman ND, Passik S. Fatigue in ambulatory AIDS patients. J Pain Symptom Manage 1998;15:159-67.
30. Barroso J, Carlson JR, Meynell J. Physiological and psychological markers associated with HIV-related fatigue. Clin Nurs Res 2003;12:49-68.
31. Sullivan PS, Dworkin MS. Prevalence and correlates of fatigue among persons with HIV infection. J Pain Symptom Manage 2003;25:329-33.
32. Cupler EJ, Otero C, Hench K, Luciano C, Dalakas MC. Acetylcholine receptor antibodies as a marker of treatable fatigue in HIV-1 infected individuals. Muscle Nerve 1996;19:1186-8.
33. Eller LS. Quality of life in persons living with HIV. Clin Nurs Res 2001;10:401-23.
34. Corless IB, Bunch EH, Kemppainen JK, Holzemer WL, Nokes KM, Eller LS, et al. Self-care for fatigue in patients With HIV. Oncol Nurs Forum 2002;29:E60-9.
35. Fighting fatigue requires battle on many fronts. AIDS Alert 1996;11:s1-2.
36. Testosterone therapy can improve mood, energy. AIDS Alert 1999;14:18-20.
37. More awareness needed in treatment of fatigue. AIDS Alert 1996;11:115-7.
38. Newshan G, Leon W. The use of anabolic agents in HIV disease. Int J STD AIDS 2001;12:141-4.
39. Rabkin JG, Ferrando SJ, Wagner GJ, Rabkin R. DHEA treatment for HIV + patients: Effects on mood androgenic and anabolic parameters. Psychoneuroendocrinology 2000;25:53-68.
40. Wagner GJ, Rabkin JG, Rabkin R. Testosterone as a treatment for fatigue in HIV + men. Gen Hosp Psychiatry 1998;20:209-13.
41. Wagner GJ, Rabkin R. Effects of dextroamphetamine on depression and fatigue in men with HIV: A double-blind, placebo-controlled trial. J Clin Psychiatry 2000;61:436-40.
42. Wagner GJ, Rabkin JG, Rabkin R. Dextroamphetamine as a treatment for depression and low energy in AIDS patients: A pilot study. J Psychosom Res 1997;42:407-11.
43. Reillo MR. Hyperbaric oxygen therapy for the treatment of debilitating fatigue associated with HIV/AIDS. J Assoc Nurses AIDS Care 1993;4:33-8.
44. de la Revilla L, Marcos Ortega B, Castro Gomez JA, Aybar Zurita R, Marin Sanchez I, Mingorance Perez I: The perception of health, social support and family function in HIV seropositivity. Aten Primaria 1994;13:161-4.
45. Goodkin K, Blaney NT, Feaster D, Fletcher MA, Baum MK, Mantero-Atienza E, et al. Active coping style is associated with natural killer cell cytotoxicity in asymptomatic HIV-1 seropositive homosexual men. J Psychosom Res 1992;36:635-50.
46. Leserman J, Petitto JM, Perkins DO, Folds JD, Golden RN, Evans DL. Severe stress, depressive symptoms and changes in lymphocyte subsets in human immunodeficiency virus-infected men: A 2-year follow-up study. Arch Gen Psychiatry 1997;54:279-85.
47. Smith MY, Egert J, Winkel G, Jacobson J. The impact of PTSD on pain experience in persons with HIV/AIDS. Pain 2002;98:9-17.
48. Wanke C. Pathogenesis and consequences of HIV-associated wasting. J Acquir Immune Defic Syndr 2004;37:S277-9.
49. Ottery FD, Walsh D, Strawford A. Pharmacologic management of anorexia/cachexia. Semin Oncol 1998;25:35-44.
50. Esposito JG, Thomas SG, Kingdon L, Ezzat S. Anabolic growth hormone action improves submaximal measures of physical performance in patients with HIV-associated wasting. Am J Physiol Endocrinol Metab 2005;289:E494-503.
51. Navario P. Medical marijuana: Shifting the paradigm. IAPAC Mon 2001;7:76-9.
52. Hall WD, Degenhardt LJ, Currow D. Allowing the medical use of cannabis. Med J Aust 2001;175:39-40.
53. Miller K, Corcoran C, Armstrong C, Caramelli K, Anderson E, Cotton D, et al. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: A pilot study. J Clin Endocrinol Metab 1998;83:2717-25.
54. Paranjape RS, Tripathy SP, Menon PA, Mehendale SM, Khatavkar P, Joshi DR, et al. Increasing trend of HIV seroprevalence among pulmonary tuberculosis patients in Pune, India. Indian J Med Res 1997;106:207-11.
55. Vogl D, Rosenfeld B, Breitbart W, Thaler H, Passik S, McDonald M, et al. Symptom prevalence, characteristics and distress in AIDS outpatients. J Pain Symptom Manage 1999;18:253-62.